Sponsor
  • ·
  • Chinese Association of
    Integrative Medicine;
    China Academy of Chinese
    Medicine Sciences
Editing
  • ·
  • Editorial Board of
    China Journal of
    Orthopaedics and Traumatology
Publishing
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
Overseas Distributor
  • ·
  • China International Book
    Trading Corporation
    P.O.Box 399,Beijing,China
    Code No.M587
Mail-order
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
    No.16A, Nanxiaojie, Dongzhimennei,
    Beijing 100700,China
    Tel:0086-10-84020925
    Fax:0086-10-84036581
    Http://www.zggszz.com
    E-mail:zggszz@sina.com
基质金属蛋白酶-13的测定在骨关节炎中作用的研究进展
Hits: 2205   Download times: 1112   Received:December 20, 2013    
作者Author单位UnitE-Mail
陈文晓 CHEN Wen-xiao 浙江中医药大学, 浙江 杭州 310053 Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, Zhejiang, China  
单方军 SHAN Fang-jun 浙江中医药大学, 浙江 杭州 310053 Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, Zhejiang, China  
金红婷 JIN Hong-ting 浙江中医药大学, 浙江 杭州 310053 Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, Zhejiang, China  
王萍儿 WANG Ping-er 浙江中医药大学, 浙江 杭州 310053 Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, Zhejiang, China  
肖鲁伟 XIAO Lu-wei 浙江中医药大学, 浙江 杭州 310053 Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, Zhejiang, China  
童培建 TONG Pei-jian 浙江中医药大学, 浙江 杭州 310053
浙江省中医骨伤研究所, 浙江 杭州 310053
Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, Zhejiang, China tongpeijian@163.com 
期刊信息:《中国骨伤》2014年27卷,第7期,第617-620页
DOI:10.3969/j.issn.1003-0034.2014.07.020
基金项目:2013浙江省科技厅第二批重大科技专项重大社会发展项目(编号:2012c13017-2)
骨关节炎是在复杂的生物学和力学因素共同作用下,软骨细胞、细胞外基质、软骨下骨三者合成与降解失衡的一种慢性、进行性疾病,其病因和病理机制目前尚未完全明确,但基质金属蛋白酶-13(MMP-13)对Ⅱ型胶原所组成三螺旋结构的降解和破坏被认为是OA发生发展的关键环节,MMP-13抑制剂的研究将会为OA的治疗提供新的思路和方法。
[关键词]:基质金属蛋白酶-13  骨关节炎  软骨,关节  胶原  综述文献
 
Research on application of determination of MMP-13 in osteoarthritis
Abstract:Osteoarthritis (OA) is a complex chronic progressive disease attacked by biological and mechanical factors and a result from the anabolic and catabolic imbalance in chondrocyte,subchondral bone and extracellular matrix(ECM). Etiology and pathological of OA are not yet entirely clear. The degradation and destruction of collagen Ⅱ caused by matrix metalloproteinase-13(MMP-13) is considered the core factor in the occurrence and development of OA. The research of MMP-13 inhibitor provide ideas and methods for the treatment of OA. In this article,the role and determination of MMP-13 in OA and the development prospect of MMP-13 inhibitor in the treatment of OA research progress were reviewed.
KEYWORDS:Matrix metalloproteinase-13  Osteoarthritis  Cartilage,articular  Collagen  Review literature
 
引用本文,请按以下格式著录参考文献:
中文格式:陈文晓,单方军,金红婷,王萍儿,肖鲁伟,童培建.基质金属蛋白酶-13的测定在骨关节炎中作用的研究进展[J].中国骨伤,2014,27(7):617~620
英文格式:CHEN Wen-xiao,SHAN Fang-jun,JIN Hong-ting,WANG Ping-er,XIAO Lu-wei,TONG Pei-jian.Research on application of determination of MMP-13 in osteoarthritis[J].zhongguo gu shang / China J Orthop Trauma ,2014,27(7):617~620
View Full Text  View/Add Comment  Download reader
Close




版权所有:Editorial Office of China Journal of Orthopaedics and Traumatology京ICP备12048066号  版权声明
地址:No.16A, Nanxiaojie, Dongzhimennei, Beijing 100700, China
电话:0086-10-84036581 传真:0086-10-84036581 Email:zggszz@sina.com